IP Library Granted Patent US 10,583,415
Granted Patent B2
US 10,583,415 · App. 16/409,608 · Granted Mar 10, 2020

De novo synthesized gene libraries

Inventors: William Banyai (San Francisco, CA); Bill James Peck (Santa Clara, CA); Andres Fernandez (San Francisco, CA); Siyuan Chen (San Mateo, CA); Pierre Indermuhle (Berkeley, CA)
Assignee: Twist Bioscience Corporation
B01J19/0046C12N15/1093C12N15/1096C12N15/66C12N15/74C40B50/18B01J2219/0059B01J2219/00313B01J2219/00317B01J2219/00378B01J2219/00497B01J2219/00585B01J2219/00587B01J2219/00596B01J2219/00605B01J2219/00612B01J2219/00619B01J2219/00623B01J2219/00637B01J2219/00709B01J2219/00722C12N15/09C40B40/06C40B50/00C40B50/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,583,415
App. No.
16/409,608
Granted
Mar 10, 2020
Kind
B2
Abstract

De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein.

Claims (22)

1. A method for synthesizing oligonucleotides, comprising:

synthesizing a plurality of oligonucleotides at a rate of extending each of the oligonucleotides by at least 10 nucleotides per hour, wherein each of the oligonucleotides has a preselected sequence, and wherein the synthesizing comprises extending each oligonucleotide by a single base in an extension reaction.

2. The method of claim 1 , wherein the rate of extending each of the oligonucleotides is at least 20 nucleotides per hour.

3. The method of claim 1 , wherein the rate of extending each of the oligonucleotides is at least 25 nucleotides per hour.

4. The method of claim 1 , wherein the plurality oligonucleotides are synthesized in parallel.

5. The method of claim 1 , wherein at least 20,000 oligonucleotides are synthesized.

6. The method of claim 1 , wherein at least 500,000 oligonucleotides are synthesized.

7. The method of claim 1 , wherein each of the oligonucleotides is at least 25 nucleotides in length.

8. The method of claim 1 , wherein the plurality of oligonucleotides are synthesized on a solid substrate.

9. The method of claim 8 , wherein the solid substrate comprises silicon, silicon dioxide or silicon nitride.

10. The method of claim 1 , wherein each of the oligonucleotides has a different preselected sequence.

11. The method of claim 1 , wherein each of the oligonucleotides comprises 100 to 200 nucleotides in length and is synthesized in less than 5 hours.

12. The method of claim 1 , wherein the rate of extending each of the oligonucleotides is at least 12 nucleotides per hour.

13. The method of claim 1 , wherein the rate of extending each of the oligonucleotides is at least 15 nucleotides per hour.

14. The method of claim 1 , wherein each of the oligonucleotides comprises 100 to 200 nucleotides in length.

15. The method of claim 1 , wherein each of the oligonucleotides comprises 80 to 200 nucleotides in length.

16. The method of claim 1 , wherein each of the oligonucleotides is at least 100 nucleotides in length.

17. The method of claim 1 , wherein each of the oligonucleotides are the same length.

18. The method of claim 1 , wherein the plurality of oligonucleotides comprise DNA.

19. The method of claim 1 , wherein the plurality of oligonucleotides comprise RNA.

20. The method of claim 1 , wherein each of the oligonucleotides comprises 100 to 300 nucleotides in length.

21. The method of claim 1 , wherein each of the oligonucleotides comprises 10 to 500 nucleotides in length.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE FIFTH ASSIGNORS EXECUTION DATE PREVIOUSLY RECORDED ON REEL 050058 FRAME 0268. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 13, 2019
From: BANYAI, WILLIAM; PECK, BILL JAMES; FERNANDEZ, ANDRES; CHEN, SIYUAN; INDERMUHLE, PIERRE
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 051287/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: BANYAI, WILLIAM; PECK, BILL JAMES; FERNANDEZ, ANDRES; CHEN, SIYUAN
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 050058/0268 →
Continuity (7)
Continuation 15377547 · Dec 13, 2016
Continuation 15187721 · Jun 20, 2016
Continuation 14885963 · Oct 16, 2015
Continuation PCTUS2014049834 · Aug 5, 2014
Provisional Application 61862445 · Aug 5, 2013
Provisional Application 61862457 · Aug 5, 2013
Related Publication 20190314783A1 · Oct 17, 2019
Cited By (18)
US 12,201,857 US 12,202,905 US 12,209,266 US 12,258,406 US 12,270,028 US 12,325,739 US 12,331,427 US 12,357,959 US 12,391,762 US 12,522,868 US 12,534,494 US 12,553,151 US 12,565,715 US 12,569,822 US 12,570,750 US 12,571,024 US 12,644,115 US 12,697,597